Similar articles

• [Concerning the contribution by F. Jesch, G. Hübner, V. Zumtobel, M. Zimmermann and K. Messmer, hydroxyethyl starch (HAS 450/0,7) in plasma and liver--course of concentration and human histologic changes [Infusionstherapie 6:112-117 (1979)].

  Thompson WL. Thompson WL. Infusionsther Klin Ernahr. 1979 Aug;6(4):262-3. Infusionsther Klin Ernahr. 1979. PMID: 90652 German. No abstract available.
• [Hydroxyethyl starch (HAS 450/0.7) in human plasma and liver. Course of concentration and histological changes].

  Jesch F, Hübner G, Zumtobel V, Zimmermann M, Messmer K. Jesch F, et al. Infusionsther Klin Ernahr. 1979 Apr;6(2):112-7. Infusionsther Klin Ernahr. 1979. PMID: 85605 German.
• All formulations of hydroxyethyl starch are not the same.

  Strauss RG. Strauss RG. Transfusion. 2007 Jul;47(7):1329-30; author reply 1330-1. doi: 10.1111/j.1537-2995.2007.01299.x. Transfusion. 2007. PMID: 17581172 No abstract available.
• [Reply to W. L. Thompson's commentary (Infusionstherapie 4:56-62 1977) on G. Lindblad's and J. Falk's study on "Course of hydroxyethyl starch and dextran concentration in blood and liver of rabbits and the histopathological consequences of hydroxyethyl starch storage (Infusionstherapie 3:301-3 1976)].

  [No authors listed] [No authors listed] Infusionsther Klin Ernahr. 1978 Apr;5(2):118-9. Infusionsther Klin Ernahr. 1978. PMID: 77255 German. No abstract available.
• Evaluation of hetastarch.

  Nakasato SK. Nakasato SK. Clin Pharm. 1982 Nov-Dec;1(6):509-14. Clin Pharm. 1982. PMID: 6192962 Review.